These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23146054)

  • 1. Hypercoagulability in β-thalassemia: a status quo.
    Cappellini MD; Poggiali E; Taher AT; Musallam KM
    Expert Rev Hematol; 2012 Oct; 5(5):505-11; quiz 512. PubMed ID: 23146054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalassemia and hypercoagulability.
    Taher AT; Otrock ZK; Uthman I; Cappellini MD
    Blood Rev; 2008 Sep; 22(5):283-92. PubMed ID: 18511163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis in thalassemia: why are we so concerned?
    Musallam KM; Taher AT
    Hemoglobin; 2011; 35(5-6):503-10. PubMed ID: 21910599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining thalassemia as a hypercoagulable state.
    Cappellini MD; Motta I; Musallam KM; Taher AT
    Ann N Y Acad Sci; 2010 Aug; 1202():231-6. PubMed ID: 20712798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia].
    Lv RY; Wen FQ; Yu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):774-8. PubMed ID: 25008893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major.
    Eldor A; Maclouf J; Lellouche F; Ben-Yashar V; Barenholz Y; Durst R; Hy-Am E; Goldfarb A; Rachmilewitz E
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():92-5. PubMed ID: 7886616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalassemia and venous thromboembolism.
    Succar J; Musallam KM; Taher AT
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011025. PubMed ID: 21713079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercoagulability in non-transfusion-dependent thalassemia.
    Cappellini MD; Musallam KM; Poggiali E; Taher AT
    Blood Rev; 2012 Apr; 26 Suppl 1():S20-3. PubMed ID: 22631037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic complications in beta-thalassemia: Beyond the horizon.
    Panigrahi I; Agarwal S
    Thromb Res; 2007; 120(6):783-9. PubMed ID: 17346783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
    Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
    Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and splenectomy: an overview.
    Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
    Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-thalassemia intermedia: a clinical perspective.
    Musallam KM; Taher AT; Rachmilewitz EA
    Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a013482. PubMed ID: 22762026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation and activation in thalassemia major patients in Indonesia.
    Setiabudy R; Wahidiyat PA; Setiawan L
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing of refractory leg ulcer in a patient with thalassemia intermedia and hypercoagulability after 14 years of unresponsive therapy.
    Levin C; Koren A
    Isr Med Assoc J; 2011 May; 13(5):316-8. PubMed ID: 21845977
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercoagulability in sickle cell disease and beta-thalassemia.
    Singer ST; Ataga KI
    Curr Mol Med; 2008 Nov; 8(7):639-45. PubMed ID: 18991650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypercoagulable state in thalassemia.
    Eldor A; Rachmilewitz EA
    Blood; 2002 Jan; 99(1):36-43. PubMed ID: 11756150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model to study thrombotic complications of thalassemia.
    Kalish Y; Malyutin Z; Shai E; Dana M; Avraham L; Jahshan N; Rachmilewitz E; Fibach E; Varon D
    Thromb Res; 2015 Mar; 135(3):521-5. PubMed ID: 25613926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.